CD166-specific CAR-T cells potently target colorectal cancer cells

Chimeric antigen receptor (CAR) T-cell therapy is emerging as an effective cancer treatment, such as for hematological malignancies, however its effectiveness as an approach to treat solid tumors, such as in colorectal cancer (CRC), remains to be better developed. One area of intense development has...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shuai, Li, Shirong, Guo, Jing, Zeng, Xiaozhu, Liang, Dandan, Zhu, Yongjie, Li, Yi, Yang, Dong, Zhao, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637812/
https://www.ncbi.nlm.nih.gov/pubmed/36327697
http://dx.doi.org/10.1016/j.tranon.2022.101575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637812/
https://www.ncbi.nlm.nih.gov/pubmed/36327697
http://dx.doi.org/10.1016/j.tranon.2022.101575

Ejemplares similares